Selecta Biosciences, Inc.

SELB · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$35-$220$35-$26
Dep. & Amort.$1$1$1$1
Deferred Tax$0-$19$0$2
Stock-Based Comp.$7$0$11$8
Change in WC$0$4-$60-$48
Other Non-Cash$4$161-$19$2
Operating Cash Flow-$24-$51-$32-$60
Investing Activities
PP&E Inv.-$9-$0-$1-$1
Net Acquisitions$0$0$14$2
Inv. Purchases$0$0-$34-$32
Inv. Sales/Matur.$0$28$20$16
Other Inv. Act.$0$7-$14-$2
Investing Cash Flow-$9$35-$15-$17
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$40$20$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$168-$13$39$53
Financing Cash Flow$168-$13$39$53
Forex Effect-$0-$0$0-$0
Net Chg. in Cash$136-$30-$7-$25
Supplemental Information
Beg. Cash$78$108$115$140
End Cash$214$78$108$115
Free Cash Flow-$33-$51-$33-$61